Adis Journals
Browse
Summary Slide.png (79.53 kB)

Are SGLT-2 Inhibitors the Future of Heart Failure Treatment? The EMPEROR-Preserved and EMPEROR-Reduced Trials

Download (79.53 kB)
media
posted on 2020-07-22, 13:57 authored by David M. Williams, Marc Evans

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Usage metrics

    Diabetes Therapy

    Categories

    Keywords

    Cardiovascular outcomesEmpagliflozinEMPEROR-preservedEMPEROR-reducedHeart failurePreserved ejection fractionReduced ejection fractionSGLT-2 inhibitorsType 2 diabetes

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC